Close menu




April 9th, 2020 | 10:32 CEST

Commerzbank, Royal Dutch Shell, Wirecard - Opportunities and Potentials

  • Investments
Photo credits: pixabay.com

Price developments on stock markets around the world have led to enormous losses for investors in recent weeks. Particularly hard hit were investors who worked leveraged with credits and had to sell their positions in connection with falling prices. An escalating situation due to the Corona Pandemic, accelerated by imbalances - a nightmare. The development of measures to curb the spread has serious social and economic consequences. There was a sell-off in all asset classes. A lot of collateral damage, but at the same time an opportunity for building a position.

time to read: 1 minutes | Author: Mario Hose
ISIN: DE000CBK1001 , GB00B03MLX29 , DE0007472060

Table of contents:


    In purchasing is the profit

    The oil price will be in the spotlight today as a video conference of OPEC+ member countries is expected to result in a cut in production. Due to the drop in demand for the black gold as a result of the Corona Crisis, the price has fallen. The oversupply must be reduced in a concerted manner by the producers in order to increase the profit margins per barrel.

    Companies like Royal Dutch Shell and Saturn Oil & Gas are therefore in the focus of investors. The CEO of Saturn Oil & Gas, John Jeffrey, recently announced that he will be prioritizing ESG criteria from now on. The appointment of dynaCERT CEO Jim Payne as a new board member supports this step. As a CleanTech company, dynaCERT has developed a hydrogen technology that will be used in the oil industry in the future.

    Growth market fertility treatment

    In a recent interview, Alison Coutts, Executive Chairman of Memphasys, announced that the company expects to begin distributing FELIX in the second half of this year. The FELIX device helps in the separation of sperm for couples who wish to have children. In addition, the medical innovation should also be able to be used for animals in the future. The market for artificial insemination is growing because more and more couples decide to have their own child at a later age and the natural chances of a successful pregnancy then decrease significantly.

    Full video with Alison Coutts

    Investors shy away from risk

    The two financial houses Commerzbank and Wirecard have also come under enormous pressure in recent weeks. While the Wirecard shares are already trading above the level of December 2019 again, the value of the Commerbank shares is still close to the all-time low. The advantage of the payment service provider Wirecard is that, despite curfews, online transactions are processed via the company's systems. At Commerzbank, there are fears that the default risks for the bank will increase with ongoing economic restrictions in connection with the Corona Crisis.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author



    Related comments:

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read

    Commented by Carsten Mainitz on September 29th, 2022 | 12:01 CEST

    Verbio, Kleos Space, KWS Saat - This news is moving share prices!

    • Space
    • Technology
    • Investments

    Increased uncertainties in geopolitics, rampant inflation with exploding commodity and energy prices, and higher interest rates are making it increasingly difficult for companies to meet the forecasts they issued at the beginning of the year. Recent examples include battery manufacturer Varta and real estate financier Hypoport, which had to withdraw their annual targets. In addition, however, a number of companies have been able to surprise on the upside despite all the challenges.

    Read